Finding Funding in Biotechnology: Keeping the Companies Alive

June 15, 2002
Mark D. Dibner

,
Michael Howell

BioPharm International, BioPharm International-06-01-2002, Volume 15, Issue 6

by Mark D. Dibner, BioAbility, LLC, and Michael Howell Biotechnology appears to be "the place to be" for venture capitalists, capturing the largest percentage increase in investment for 2001. The value of biotech companies has risen sharply, and many economists are predicing an end to the IPO drought.